Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer

Phase 3

Active, not recruiting

• Conditions: Cancer
• Interventions: Behavioral: survey, questionaire

• Registration Number: NCT01579552
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

The purpose of this study is to empower women to improve their health in two very important areas: breast and heart health. This twelve-month study will compare two methods of informing participants about potential health risks and ways to stay healthy.

The EMPOWER Study has been designed for adult women who were treated for a childhood cancer with chest radiation.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-07
• Study First Submitted: 2012-04-03
• Study First Submitted QC: 2012-04-17
• Study First Posted: 2012-04-18
• Status Verified: 2024-08
• Last Update Submitted: 2024-08-09
• Last Update Posted: 2024-08-12
• Primary Completion: 2025-07
• Study Completion: 2025-07

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: Female
• Target Recruitment: 360

Inclusion Criteria

• Participant in the CCSS cohort
• Diagnosed with a childhood cancer prior to 21 years of age
• Treated with > 20 Gy of chest radiation (mantle, mediastinal, lung, or chest)
• Age 25-49 years at time of enrollment into the study
• Interval from chest radiation to the time of enrollment of > 8 years
• No mammogram or other breast imaging study in the 24 months prior to enrollment
• English-speaking - The University of Colorado AMC Denver and MSKCC group are not capable of or equipped for conducting a brief motivational interviews by telephone in another language.

Read More

Exclusion Criteria

• Diagnosed with breast cancer
• Participated in the Project VISION feasibility study (exposed to part of the intervention)

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention Group	survey, questionaire	The EMPOWER intervention trial is a 12-month study of 360 women from the Childhood Cancer Survivor Study who have previously been treated with chest radiation, are 25 to 49 years of age at the time of enrollment, are 8 years or more since their chest radiation, and have not had a mammogram or other breast imaging study in the preceding two years. Following a baseline questionnaire, participants will be randomized to the attention control group (N=120) or the intervention group (N=240).
attention control group	survey, questionaire	The EMPOWER intervention trial is a 12-month study of 360 women from the Childhood Cancer Survivor Study who have previously been treated with chest radiation, are 25 to 49 years of age at the time of enrollment, are 8 years or more since their chest radiation, and have not had a mammogram or other breast imaging study in the preceding two years. Following a baseline questionnaire, participants will be randomized to the attention control group (N=120) or the intervention group (N=240).

Primary Outcome Measures

Name	Time	Method
efficacy	12 months	Determine the efficacy of an intervention, consisting of mailed tailored print materials followed by a telephone-delivered Brief Motivational Interview, on mammogram screening rates compared with an attention control. Mammogram completed by 12-month questionnaire (confirmed by medical record)

Secondary Outcome Measures

Name	Time	Method
Moderating factors	12 months	By including interaction terms in the model, we will assess potential moderating factors such as age, race/ethnicity, health insurance, \& other sociodemographic variables. Moderating effects can be adequately addressed through interactions between the intervention \& the above mentioned covariates.124 An interaction with the treatment group indicator suggests differential effectiveness, and moderator variables with statistically significant interactions will remain in the model. Interactions will be estimated using crossproduct terms between the intervention indicator \& the mediating variable.
Mediating factors	12 months	Based on results from the MPS \& breast ca screening intervention trials among women in the general pop or familial risk, we are a priori interested in mediating effect of 5 variable domains: knowledge of screening guidelines, breast ca health beliefs, decisional balance of the pros \& cons of mammography, self-efficacy, \& psychological factors. For each of these domains, a global or subscale score will be used as appropriate. For ex, from the BSI-18, a global score of psychological symptoms \& a subscale score for each group of symptoms can be estimated.
Economic analysis	12 months	Replication costs of intervention: dollar cost; time cost (per person); • Costs resulting from intervention: total cost of screening/diagnostic imaging, diagnostic procedures, breast surgery, non-procedure breast-related physician visits
Breast MRI completed by 12-month questionnaire	12 months	(confirmed by medical record); • Barriers to completing breast MRI: moderating/mediating variables listed above

Trial Locations

Locations (1)

St. Jude Children's Research Hospital; 🇺🇸 Memphis, Tennessee, United States